Scientists test new antibody combo to control HIV without daily pills
NCT ID NCT05281510
Summary
This study tested the safety of a new combination treatment for HIV. It involved 20 women who were already on successful HIV medication. Researchers gave them two long-acting antibodies and an immune system booster, then carefully paused their regular pills to see if the new treatment could keep the virus under control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FRESH Clinical Research Site: Females Rising through Education, Support and Health
Umlazi, 4066, South Africa
Conditions
Explore the condition pages connected to this study.